Trehu Elizabeth

Chief Medical Officer at Jounce Therapeutics, Inc.

Sold, on record
$570k
Dollars the filings state
Form 4 sales
10
Latest Jan 10, 2023
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 7, 2020 2020

    Sold 2,624 shares at $7.78 ($20k)

    Trehu Elizabeth, Chief Medical Officer

    Sold 4.4% of holdings ($460k position)56,565 shares left0.6x usual sizeFiling

  2. 2 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Aug 17, 2020 +223 days

    Sold 2,182 shares at $4.71 ($10k)

    Trehu Elizabeth, Chief Medical Officer

    Sold 2.8% of holdings ($371k position)76,633 shares leftFiling

  3. 3 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 8, 2021 +144 days

    Sold 5,298 shares at $6.89 ($36k)

    Trehu Elizabeth, Chief Medical Officer

    Sold 6.9% of holdings ($528k position)71,335 shares left2.3x usual sizeFiling

  4. 4 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 20, 2021 +12 days

    Sold 6,500 shares at $12.01 ($78k)

    Trehu Elizabeth, Chief Medical Officer

    Sold 8.4% of holdings ($935k position)71,335 shares left2.6x usual sizeFiling

  5. 5 Form 4 sale Jounce Therapeutics, Inc.Unusual
    Mar 31, 2021 +70 days

    Sold 13,500 shares at $10.09 ($136k)

    Trehu Elizabeth, Chief Medical Officer

    Sold 12.6% of holdings ($1.1M position)93,585 shares left5.1x usual sizeFiling

  6. 6 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 10, 2022 +285 days

    Sold 8,383 shares at $6.88 ($58k)

    Trehu Elizabeth, Chief Medical Officer

    Sold 9% of holdings ($644k position)85,202 shares left1.4x usual sizeFiling

  7. 7 Form 144 notice Jounce Therapeutics, Inc.Notice
    Jan 6, 2023 +361 days

    Filed to sell 10,000 shares ($11k)

    Trehu Elizabeth, Officer

    10b5-1 plan1.3x usual sizeFiling

  8. 8 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 10, 2023 +4 days

    Sold 9,285 shares at $1.11 ($10k)

    Trehu Elizabeth, Chief Medical Officer

    Sold 8.2% of holdings ($125k position)103,417 shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Trehu Elizabeth
Source
Jan 10, 2023Jan 11, 2023Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale9,285$10k8.2%Plan not statedSEC
Jan 6, 2023Jan 6, 2023Jounce Therapeutics, Inc.OfficerForm 144 notice10,000$11kNoticeSEC
Jan 10, 2022Jan 11, 2022Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale8,383$58k9.0%Plan not statedSEC
Mar 31, 2021Mar 31, 2021Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale13,500$136k12.6%UnusualSEC
Jan 20, 2021Jan 22, 2021Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale6,500$78k8.4%Plan not statedSEC
Jan 8, 2021Jan 11, 2021Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale5,298$36k6.9%Plan not statedSEC
Aug 17, 2020Aug 18, 2020Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale2,182$10k2.8%Plan not statedSEC
Jan 7, 2020Jan 10, 2020Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale2,624$20k4.4%Plan not statedSEC
Aug 16, 2019Aug 16, 2019Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale2,336$9k3.8%Plan not statedSEC
Mar 8, 2018Mar 12, 2018Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale4,545$114k100.0%UnusualSEC
Mar 5, 2018Mar 7, 2018Jounce Therapeutics, Inc.Chief Medical OfficerForm 4 sale4,545$98k100.0%UnusualSEC